Catheter-induced pulmonary artery rupture in the setting of cardiopulmonary bypass

Urschel, John D.; Myerowitz, P. David

doi:10.1016/0003-4975(93)90912-2

Cited by 69 publications

(34 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Mechanical complications of Swan-Ganz catheter application can be treated surgically (reconstruction of pulmonary artery, lobectomy, lung resection) [12] or endovascularly (embolization) [3, 18, 19]. Endovascular therapy is a safe, quick and low cost alternative to surgical techniques [20].…”

Section: Discussionmentioning

confidence: 99%

Endovascular treatment of PA pseudoaneurysm caused by Swan-Ganz catheter

Rudziński¹,

Demkow²,

Michałowska³

et al. 2014

pwki

View full text Add to dashboard Cite

The following case report describes a complication of Swan-Ganz catheterization and its endovascular treatment with a single coil. Application of this particular catheter in the pulmonary artery during cardiac surgery may lead to mechanical perforation and creation of an extravascular sac, which is called a pseudoaneurysm. There are different methods that lead to tamponade or closure of the leakage. Interventional cardiology procedures are nowadays the most appropriate way of treatment of Swan-Ganz catheter induced vascular complications.

show abstract

Section: Discussionmentioning

confidence: 99%

Endovascular treatment of PA pseudoaneurysm caused by Swan-Ganz catheter

Rudziński¹,

Demkow²,

Michałowska³

et al. 2014

pwki

View full text Add to dashboard Cite

show abstract

“…Sudden onset of hemoptysis is an alarm signal and, in case of pulmonary artery rupture, indicates an emergency condition with a possibly fatal outcome. The reported incidence of pulmonary artery rupture during right heart catheterization is between 0.2% and 1.0% with a mortality greater than 50% [3][4][5]. However, all these figures arise from small studies and case reports.…”

Section: Discussionmentioning

confidence: 99%

Selective embolization of a pulmonary artery rupture caused by a Cournand catheter

Kaiser

Hügli

Haegeli

et al. 2004

Cathet Cardio Intervent

View full text Add to dashboard Cite

show abstract

“…Numerous complications have been reported with an incidence of 5%-50% [5,6]. One of the most serious is pulmonary artery rupture with a very high mortality of 45%-65%, usually caused by asphyxia and/or exsanguination due to frequently uncontrollable hemorrhage [7]. The clinical manifestations vary from minimal to massive hemoptysis flooding the interparenchymal space and massive hemorrhage into the pleural cavity.…”

Section: Discussionmentioning

confidence: 99%

Rescue PTCA complicated by pulmonary artery rupture after tPA and abciximab

Chadow

Gaba

Safi

et al. 1999

Cathet. Cardiovasc. Intervent.

View full text Add to dashboard Cite

Since the introduction of pulmonary artery catheterization for hemodynamic monitoring, several complications associated with its use have been described. Pulmonary artery rupture is an infrequent complication of flow‐directed pulmonary artery catheters. We report a case of pulmonary artery rupture complicating rescue PTCA in the presence of systemic platelet inhibition with abciximab (Reopro), anticoagulation, and thrombolytic therapy. With the increasing use of these medications in patients undergoing acute coronary interventions, particularly those patients requiring hemodynamic monitoring, this uncommon but potentially fatal complication may be seen more frequently. Cathet. Cardiovasc. Intervent. 46:89–91, 1999. © 1999 Wiley‐Liss, Inc.

show abstract

Catheter-induced pulmonary artery rupture in the setting of cardiopulmonary bypass

Cited by 69 publications

References 40 publications

Endovascular treatment of PA pseudoaneurysm caused by Swan-Ganz catheter

Endovascular treatment of PA pseudoaneurysm caused by Swan-Ganz catheter

Selective embolization of a pulmonary artery rupture caused by a Cournand catheter

Rescue PTCA complicated by pulmonary artery rupture after tPA and abciximab

Contact Info

Product

Resources

About